1. Home
  2. NINE vs INTS Comparison

NINE vs INTS Comparison

Compare NINE & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NINE
  • INTS
  • Stock Information
  • Founded
  • NINE 2011
  • INTS 2012
  • Country
  • NINE United States
  • INTS United States
  • Employees
  • NINE N/A
  • INTS 16
  • Industry
  • NINE Oilfield Services/Equipment
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • NINE Energy
  • INTS Health Care
  • Exchange
  • NINE Nasdaq
  • INTS Nasdaq
  • Market Cap
  • NINE 30.7M
  • INTS 8.7M
  • IPO Year
  • NINE 2018
  • INTS 2023
  • Fundamental
  • Price
  • NINE $0.68
  • INTS $0.54
  • Analyst Decision
  • NINE
  • INTS Strong Buy
  • Analyst Count
  • NINE 0
  • INTS 3
  • Target Price
  • NINE N/A
  • INTS $8.50
  • AVG Volume (30 Days)
  • NINE 694.5K
  • INTS 363.7K
  • Earning Date
  • NINE 05-07-2025
  • INTS 05-20-2025
  • Dividend Yield
  • NINE N/A
  • INTS N/A
  • EPS Growth
  • NINE N/A
  • INTS N/A
  • EPS
  • NINE N/A
  • INTS N/A
  • Revenue
  • NINE $562,450,000.00
  • INTS N/A
  • Revenue This Year
  • NINE $10.08
  • INTS N/A
  • Revenue Next Year
  • NINE $2.01
  • INTS N/A
  • P/E Ratio
  • NINE N/A
  • INTS N/A
  • Revenue Growth
  • NINE N/A
  • INTS N/A
  • 52 Week Low
  • NINE $0.60
  • INTS $0.50
  • 52 Week High
  • NINE $2.07
  • INTS $5.28
  • Technical
  • Relative Strength Index (RSI)
  • NINE 36.31
  • INTS 18.34
  • Support Level
  • NINE $0.60
  • INTS $0.55
  • Resistance Level
  • NINE $0.91
  • INTS $0.59
  • Average True Range (ATR)
  • NINE 0.07
  • INTS 0.12
  • MACD
  • NINE -0.00
  • INTS -0.02
  • Stochastic Oscillator
  • NINE 25.00
  • INTS 4.71

About NINE Nine Energy Service Inc.

Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: